Manufacture and Supply of Dextrose Injection 5%, USP

This subcontract involves the manufacture and supply of sterile Dextrose Injection 5% for prime contractors supporting the Defense Logistics Agency medical supply chain. The scope of work includes compounding Hydrous Dextrose USP with Water for Injection USP, filling 1,000 ML containers, and performing sterilization and quality testing to ensure full USP compliance. All production must occur within an FDA-approved facility using pharmaceutical-grade equipment. The contractor is responsible for delivering finished, packaged containers that adhere to DLA RP001 packaging standards. This requirement falls under NAICS code 325412 and is managed by the Department of Defense Medical Supply Chain Pharm FSA. The performance location is designated as FPO 09592-1200, with a response deadline of September 8, 2026.